Published online Apr 15, 2024. doi: 10.4251/wjgo.v16.i4.1256
Peer-review started: November 5, 2023
First decision: December 20, 2023
Revised: December 27, 2023
Accepted: February 1, 2024
Article in press: February 1, 2024
Published online: April 15, 2024
Processing time: 157 Days and 22 Hours
Pancreatic ductal adenocarcinoma (PDAC) remains the deadliest of the common cancers, with little change in patient survival in the past several decades. One of the biggest challenges of the management of PDAC that physicians often encounter is that the early detection in high-risk individuals and the early diagnosis of patients with suspected symptoms. Precise staging of PDAC is vital not only in making treatment decisions, but also in evaluating prognosis.
Radiomics, the generation of minable high throughput data through conversion of digital computed tomography (CT) or magnetic resonance imaging images, allows obtaining additional insight into pancreatic tissue heterogeneity. CT-based radiomics diagnostic approach could serve as a promising non-invasive method in differential diagnosis between early- and late-stage PDAC.
This study aimed to develop a radiomics-based diagnostic approach with a robust noninvasive diagnostic potential for identifying patients with early-stage PDAC.
A total of 71 patients with pathologically proved PDAC based on surgical resection who underwent contrast-enhanced-CT within 30 d prior to surgery were included in the study. Radiomics features were extracted from the region of interest (ROI) for each patient using Analysis Kit software. The most important and predictive radiomics features were selected using Mann-Whitney U test, univariate logistic regression analysis, and minimum redundancy maximum relevance (MRMR) method. Random forest (RF) method was used to construct the radiomics model, and 10-times leave group out cross-validation (LGOCV) method was used to validate the robustness and reproducibility of the model.
A total of 792 radiomics features (396 from late arterial phase and 396 from portal venous phase) were extracted from the ROI for each patient. Nine most important and predictive features were selected using Mann-Whitney U test, univariate logistic regression analysis, and MRMR method. RF method was used to construct the radiomics model with the nine most predictive radiomics features, which showed a high discriminative ability with 97.7% accuracy, 97.6% sensitivity, 97.8% specificity, 98.4% positive predictive value, and 96.8% negative predictive value. The radiomics model was proved to be robust and reproducible using 10-times LGOCV method with an average area under the curve of 0.75 by the average performance of the 10 newly built models.
This study demonstrated that CT-based radiomics diagnostic approach could be used to differentiate between early- and late-stage PDAC.
This study developed a radiomics-based diagnostic approach with a robust noninvasive diagnostic potential for identifying patients with early-stage PDAC. Large-scale prospective cohort studies, preferably multi-center, to validate the potential value of the radiomics diagnostic approach in differentiating early from late stage PDAC are in order.